TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Библиографические подробности
Главный автор:	Afroza, Halima
Другие авторы:	Talukder, Mesbah
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2024
Предметы:	Psoriasis Alopecia TNF-α inhibitor FAERS ROR Disproportionality analysis
Online-ссылка:	http://hdl.handle.net/10361/22075

Схожие документы

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
по: Islam, Nahidul
Опубликовано: (2023)

Isolation and identification of α-amylase producing soil microorganisms and partial characterization of α-Amylase enzyme
по: Tamanna, Shams Tahsin
Опубликовано: (2020)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
по: Islam, S.M. Zahidul
Опубликовано: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
по: Khandker, Tahia Anjum
Опубликовано: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
по: Akter, Anika
Опубликовано: (2022)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
по: Meem, Manila
Опубликовано: (2023)

Inhibition of Fibroblast Activation Protein alpha (FAP-α) in Colorectal Cancer
по: Tabassum, Azwada
Опубликовано: (2021)

Identification of FAP inhibitors using in silico simulation study
по: Deeba, Maliha Tasnim
Опубликовано: (2018)

Biologics and Biosimilars as Treatment Options for Psoriasis
по: Moya, Amena Khatun
Опубликовано: (2023)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
по: Onanna, Kazi
Опубликовано: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
по: Jahan, Safrin
Опубликовано: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
по: Islam, Saidul
Опубликовано: (2022)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
по: Bishakha, Adwiza Chakraborty
Опубликовано: (2024)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
по: Bakar, Osama Bin Abu
Опубликовано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
по: Karim, Azrin
Опубликовано: (2024)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
по: Oshin, Sadia Afrin
Опубликовано: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
по: Haque, Mushfiqul
Опубликовано: (2019)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
по: Mahin, Md. Tamjidur Rahman
Опубликовано: (2024)

Female Alopecia
по: TrÃ¼eb
Опубликовано: (2013)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
по: Khan, Muidul Hasan
Опубликовано: (2024)

Induced pluripotent stem cells: a novel tool for modelling and treating Parkinson’s disease
по: Tanin, Nahid Sultana
Опубликовано: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
по: Sorno, Rubina Haque
Опубликовано: (2024)

Detection of skin diseases using deep learning
по: Shodoy, Masuk Ur Rahman
Опубликовано: (2024)

Pharmacoepidemiology and Pharmacovigilance

Synthesis and sar o acne medication
по: Naureen, Tasnia
Опубликовано: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
по: Fred, Namanda Rogers
Опубликовано: (2021)

Importance of biologically active agents over other therapies in Rheumatoid Arthritis- a review
по: Mehreen, Elnaj
Опубликовано: (2021)

HPLC method development for the analysis of linagliptin
по: Mimiya, Ruhani Amrin
Опубликовано: (2020)

RIPK pathway, as a potential target, for cancer treatment - a review
по: Jahan, Nusrat
Опубликовано: (2024)

Importance of biologics in rheumatoid arthritis management
по: Riyadh, S. M.
Опубликовано: (2022)

Pharmacovigilance in the European Union
по: Kaeding
Опубликовано: (2017)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
по: Ratu, Tabassum
Опубликовано: (2024)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
по: Nour, Sabrina
Опубликовано: (2019)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
по: Ishrat, Nowshin
Опубликовано: (2024)

Immunotherapy in the Management of Lung Cancer
по: Tasnim, Humayra
Опубликовано: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
по: Emon, Kamrul Hasan
Опубликовано: (2022)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
по: Rahman, Towsifur
Опубликовано: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
по: Mirza, Maisa Tasnim
Опубликовано: (2023)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
по: Rahman, Ahadina
Опубликовано: (2018)